Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cell Prolif ; 57(4): e13564, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-37853840

RESUMEN

'Human neural stem cells' jointly drafted and agreed upon by experts from the Chinese Society for Stem Cell Research, is the first guideline for human neural stem cells (hNSCs) in China. This standard specifies the technical requirements, test methods, test regulations, instructions for use, labelling requirements, packaging requirements, storage requirements, transportation requirements and waste disposal requirements for hNSCs, which is applicable to the quality control for hNSCs. It was originally released by the China Society for Cell Biology on 30 August 2022. We hope that publication of the guideline will facilitate institutional establishment, acceptance and execution of proper protocols, and accelerate the international standardization of hNSCs for clinical development and therapeutic applications.


Asunto(s)
Células-Madre Neurales , Trasplante de Células Madre , Humanos , Diferenciación Celular , China
2.
Yao Xue Xue Bao ; 47(6): 769-72, 2012 Jun.
Artículo en Zh | MEDLINE | ID: mdl-22919725

RESUMEN

This proficiency testing program is established to evaluate the pharmaceutical preparation analysis capacity of laboratories recommended by 18 countries and economies. It was authorized by Asia Pacific Laboratory Accreditation Cooperation (APLAC), and organized by Shanghai Institute for Food and Drug Control (SIFDC) and China National Accreditation Service for Conformity Assessment (CNAS). The 0.3sigma test is used to evaluate the homogeneity and stability of the proficiency testing sample. The results of the laboratories were assessed by Z-score. The robust average and the robust standard deviation of the participants' results were calculated as assigned value and standard deviation for performance assessment of hydrochlorothiazide and captopril using robust statistics. Thirty-three of 38 laboratories recommended by 18 countries and economies sent their results back. Twenty-four laboratories' results were observed as satisfactory. Five laboratories were identified as having reported at least one questionable result. Four laboratories were identified as having reported at least one unsatisfactory result.


Asunto(s)
Ensayos de Aptitud de Laboratorios , Preparaciones Farmacéuticas/química , Acreditación , Captopril/análisis , Combinación de Medicamentos , Estabilidad de Medicamentos , Hidroclorotiazida/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA